Canagliflozin causes glycosuria (up to 70 grams/day)
concluded that, Participants in the tirzepatide group were more likely to have weight reductions of at least 10%... and tirzepatide was superior to treatment with semaglutide Worth notingthe study referenced here was funded by Eli Lilly, which manufactures the drugs Mounjaro and Zepbound
These medications, originally developed to treat type 2 diabetes and obesity, were associated with reduced risks of hospitalization due to alcohol use disorder among individuals who also had comorbid obesity or diabetes
Advanced oxidation protein products attenuate the autophagy-lysosome pathway in ovarian granulosa cells by modulating the ROS-dependent mTOR-TFEB pathway
Micha R, Wallace SK, Mozaffarian D
GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis